Koyfin Home > Directory > Health Care > Anika Therapeutics > Issuance of Common Stock

Anika Therapeutics Issuance of Common Stock Chart (ANIK)

Anika Therapeutics annual/quarterly Issuance of Common Stock from 2010 to 2020.
  • Anika Therapeutics Issuance of Common Stock for the quarter ending June 06, 2020 was $0m a 98.53% increase of 0m year over year
  • Anika Therapeutics Issuance of Common Stock for the last 12 months ending June 06, 2020 was $22m a 1.75% increase of 0m year over year
  • Anika Therapeutics Annual Issuance of Common Stock for 2019 was $22m a 86.97% increase of 19m from 2018
  • Anika Therapeutics Annual Issuance of Common Stock for 2018 was $3m a 89.12% increase of 3m from 2017
  • Anika Therapeutics Annual Issuance of Common Stock for 2017 was $0m a -220.70% decrease of -1m from 2016
Other Cash Flow Metrics:
  • Anika Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $11m a 35.61% increase of 4m year over year
  • Anika Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $9m a 40.85% increase of 4m year over year
  • Anika Therapeutics Total Revenue for the quarter ending December 12, 2018 was $27m a 21.12% increase of 6m year over year
View Chart On Koyfin

Quarterly ANIK Issuance of Common Stock Data

06/2020$0m
12/2019$0m
09/2019$22m
06/2019$0m
03/2019$0m
12/2018$0m
09/2018$0m
06/2018$2m
03/2018$1m
12/2017$0m

Annual ANIK Issuance of Common Stock Data

2019$22m
2018$3m
2017$0m
2016$1m
2015$1m
2014$2m
2013$3m
2012$0m
2011$0m
2010$0m